Preliminary study of immunomagnetic quantification of circulating tumor cells in patients with advanced disease
- 1 March 2005
- Vol. 65 (3), 616-621
- https://doi.org/10.1016/j.urology.2004.10.053
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Prognostic factors for survival in patients with hormone-refractory prostate cancer (HRPC) after initial androgen deprivation therapy (ADT)Urologic Oncology: Seminars and Original Investigations, 2003
- Prognostic Significance of Reverse Transcriptase Polymerase Chain Reaction for Prostate-Specific Antigen in Metastatic Prostate Cancer: A Nested Study Within CALGB 9583Journal of Clinical Oncology, 2003
- Detection and isolation of prostate cancer cells from peripheral blood and bone marrowUrology, 2003
- The Current State of Hormonal Therapy for Prostate CancerCA: A Cancer Journal for Clinicians, 2002
- Prognostic Significance of Reverse Transcriptase Polymerase Chain Reaction for Prostate-Specific Antigen in Men With Hormone-Refractory Prostate CancerJournal of Clinical Oncology, 2001
- Identification and characterization of circulating prostate carcinoma cellsCancer, 2000
- Reverse Transcriptase Polymerase Chain Reaction for Prostate Specific Antigen in the Management of Prostate CancerJournal of Urology, 1997
- Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinomaUrology, 1997
- Detection of intact prostate cancer cells in the blood of men with prostate cancerUrology, 1997
- Sensitive Detection of Prostatic Hematogenous Tumor Cell Dissemination Using Prostate Specific Antigen and Prostate Specific Membrane-Derived Primers in the Polymerase Chain ReactionJournal of Urology, 1995